Evidence map›Paper›PMID 42154357›Full record

ArticleDiscover oncology2026

Disappearance of histone H3F3A mutation in metastatic giant cell tumor of bone during long term follow up.

Takashi Ariizumi, Naoki Oike, Yudai Murayama, Tomohiro Miyazaki, Hajime Umezu, Hiroyuki Kawashima, Akira Ogose

Abstract read
In one paragraph

Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Takashi AriizumiDivision of Orthopedic Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan.
Naoki OikeDivision of Orthopedic Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan. naoki1112y@gmail.com.
Yudai MurayamaDivision of Orthopedic Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan.
Tomohiro MiyazakiDivision of Orthopedic Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan.
Hajime UmezuDivision of Pathology, Niigata University Hospital, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan.
Hiroyuki KawashimaDivision of Orthopedic Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan.
Akira OgoseDepartment of Orthopedic Surgery, Uonuma Kikan Hospital, 4132 urasa, Minamiuonuma city, Niigata, 949-7302, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGiant cell tumor of bone (GCTB) is a locally aggressive tumor that rarely metastasizes, although a small subset undergoes malignant transformation. H3F3A driver mutations have been recognized as characteristic molecular features of GCTB. We describe a case of a refractory GCTB with disappearance of the H3F3A mutation and that later developed a malignancy within the preexisting tumor. CASE PRESENTATION: A 22-year-old male was diagnosed with GCTB and underwent multiple surgeries for recurrence and lung metastases. The tumor relapsed in the knee, soft tissue, and lungs and required repeated resections. All relapsed tumor tissues were positive for H3F3A mutation. A large lung metastatic tumor developed 35 years after the initial surgery. The specimen from the last lung metastasis showed no significant changes in the morphology and characteristics of GCTB, despite the disappearance of the H3F3A mutation. Subsequently, liver and bone metastases appeared, and chemotherapy was initiated for presumed malignant transformation. Despite treatment, the disease progressed, and the patient died.

conclusionThe disappearance of the H3F3A mutation may be associated with malignant transformation in GCTB, whereas our findings suggest that it does not correspond to the tumor's morphological or biological characteristics.

Indexed as

Case reportGiant cell tumor of boneH3F3ARANKLTRAP

Identifiers

PMID42154357
PMCPMC13357467

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.